Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Ceribell, Inc.

Get SEC filing alerts via email and in your feed for Ceribell, Inc.

CBLL

Ceribell, Inc.

About Ceribell, Inc.

CeriBell, Inc. develops point-of-care EEG systems utilizing portable hardware and AI algorithms to enable rapid seizure detection and continuous monitoring in acute care settings. Its flagship Ceribell System simplifies EEG deployment, supports bedside interpretation, and improves clinical outcomes while reducing hospital costs. Serving hospitals and healthcare providers, the company aims to expand neurological diagnostics and become the standard for brain monitoring in critical care.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Ceribell, Inc.

1
1
Ceribell, Inc. Ceribell Reports 29% Revenue Growth to $26.5 Million in Q1 2026 Despite Increased Net Loss

Via official filing (AI summary) | 24 days ago | 0 comments

2
1
Ceribell, Inc. Ceribell, Inc. Reports 36% Revenue Growth and FDA Clearances for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Ceribell, Inc. Ceribell Reports 31% Revenue Growth to $22.6 Million in Q3 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Ceribell, Inc. Ceribell Reports 38% Revenue Growth to $21.2 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Ceribell, Inc. Ceribell Reports 42% Revenue Growth to $20.5 Million in Q1 2025, Despite Increased Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments